학술논문
Potential mitigating impact of a dipeptidyl peptidase-IV inhibitor, vildagliptin, on oxazolone-induced ulcerative colitis: Targeting the role of PI3K/AKT/mTOR and AMPK/Nrf2 signaling pathways
Document Type
Article
Author
Source
In International Immunopharmacology 30 May 2024 133
Subject
Language
ISSN
1567-5769